Don't miss the 11/27 webinar "Targeting Drug Resistance in Solid Tumors Using CRISPR-Directed Gene Editing" by our collaborator Kelly Banas. Sign up here: https://lnkd.in/eWEdyaaj #CRISPR #GeneEditing
We're excited to see Kelly Banas present for CRISPR Medicine News's webinar next week! She'll be discussing her team's development of a unique strategy to disrupt NRF2, a key gene involved in drug resistance in solid tumors, to augment standard of care therapies. This is research that she's grown intimately familiar with over the past nine years, and we're proud to see her go in front of an international stage to present it to the public. Find the link to the webinar in our comments and sign up today to reserve your spot.